Genmab ADR (NASDAQ: GMAB) is -1.29% lower on its value in year-to-date trading and has touched a low of $17.24 and a high of $30.41 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GMAB stock was last observed hovering at around $20.42 in the last trading session, with the day’s gains setting it 0.18%.
Currently trading at $20.60, the stock is 2.18% and 0.77% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.79 million and changing 0.88% at the moment leaves the stock -8.94% off its SMA200. GMAB registered -30.69% loss for a year compared to 6-month loss of -8.69%.
The stock witnessed a 13.25% gain in the last 1 month and extending the period to 3 months gives it a 5.80%, and is -2.60% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.15% over the week and 2.82% over the month.
Genmab ADR (GMAB) has around 2682 employees, a market worth around $12.66B and $3.12B in sales. Current P/E ratio is 11.76 and Fwd P/E is 11.55. Profit margin for the company is 36.30%. Distance from 52-week low is 19.52% and -32.26% from its 52-week high. The company has generated returns on investments over the last 12 months (21.67%).
The EPS is expected to shrink by -11.31% this year
The shares outstanding are 635.40M, and float is at 614.73M with Short Float at 0.33%.
The top institutional shareholder in the company is ALLIANCEBERNSTEIN L.P. with over 15.24 million shares valued at $382.93 million. The investor’s holdings represent 23.4845 of the GMAB Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.08 million shares valued at $127.67 million to account for 7.8301 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 4.23 million shares representing 6.5161 and valued at over $108.15 million, while HARDING LOEVNER LP holds 4.2657 of the shares totaling 2.77 million with a market value of $69.61 million.
